Voluntary corporate emissions targets not enough to create real climate action
Imperial and CNRS strengthen UK-France science with new partnerships
New AI startup accelerator led by Imperial opens for applications
Developing interventions that will regulate the haematopoietic system and improve current therapies and prevent haematological and infectious disease